Doxorubicin has produced significant therapeutic responses in a number of solid tumours and haematologic malignancies, and is commonly used in the treatment of the following tumours: carcinoma of the breast, carcinoma of the lung, carcinoma of the ovary, transitional cell bladder cancer, neuroblastoma, Wilm's tumour,...
Model No.: 50mg
Function: Nutritional Therapeutics
Certification: GMP
Doxorubicin Hydrochloride For Injection: Injection
Transportation: Ocean,Land,Air
Payment Type: L/C,T/T,D/P
Incoterm: FOB,CFR,CIF
carcinoma of the breast, carcinoma of the lung, carcinoma of the ovary, transitional cell bladder cancer, neuroblastoma, Wilm's tumour, soft tissue sarcomas, osteosarcoma, acute lymphocytic - lymphoblastic leukaemia, acute myelogenous leukaemia, non-Hodgkin's lymphoma, Hodgkin's disease.
Doxorubicin has also shown antitumour activity in the following adult and paediatric malignancies:carcinoma of the thyroid, carcinoma of the endometrium, carcinoma of the head and neck, carcinoma of the stomach, primary hepatocellular carcinoma, non-seminomatous carcinoma of the testis, carcinoma of the prostate, Ewing's sarcoma, rhabdomyosarcoma, multiple myeloma, chronic leukaemias.
If you are a distributor, please inquire with us about product registration, importing and/or marketing our products in your country or region.
If you are a consumer, don't hesitate to contact us about more information for this product.
